OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.990
-0.050 (-2.45%)
At close: Oct 10, 2025, 4:00 PM EDT
1.990
0.00 (0.00%)
After-hours: Oct 10, 2025, 8:00 PM EDT

OS Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2022
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
6389---
Market Cap Growth
-8.07%----
Enterprise Value
60.1787.8714.5710.186.99
Last Close Price
1.994.28---
PE Ratio
--4.86000
PB Ratio
11.94-27.34000
P/TBV Ratio
8.44-16.22---
P/FCF Ratio
--12.27000
P/OCF Ratio
--12.27000
EV/EBITDA Ratio
--16.32-8.61-3.09-2.53
EV/EBIT Ratio
--12.90-3.36-2.29-1.45
EV/FCF Ratio
--12.07-4.85-2.68-1.58
Debt / Equity Ratio
00-0.61-0.59-0.62
Debt / EBITDA Ratio
---8.63-3.14-2.56
Debt / FCF Ratio
---4.86-2.73-1.60
Quick Ratio
0.811.200.000.030.09
Current Ratio
1.031.200.030.080.09
Return on Equity (ROE)
-377.58%76.56%37.48%43.13%64.81%
Return on Assets (ROA)
-192.34%-215.05%-664.43%-1064.99%-1484.35%
Return on Capital (ROIC)
-321.43%-61.87%-37.86%-178.25%-281.42%
Return on Capital Employed (ROCE)
-392.64%59.24%29.39%100.95%152.58%
Earnings Yield
-25.81%-20.56%---
FCF Yield
-18.36%-8.15%---
Buyback Yield / Dilution
0.00%-7.53%---
Total Shareholder Return
--7.53%---
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q